News

AOD-9604 vs. Semaglutide: Bone Loss Risk in Menopausal Weight Loss
Comparing AOD-9604 and semaglutide for menopausal weight loss reveals distinct mechanisms but similar bone loss risks. Research quality remains limited for both compounds in this population. Read more...